IMPROVING PATIENT’S QUALITY OF LIFE USING A CERAMIDE CONTAINING MOISTURISER AS MONOTHERAPY IN MILD TO MODERATE ATOPIC DERMATITIS

Neena Khanna, Annie Jain, Kirit Chawda, Rima Rakshit, Hemali Pandya, Nada Baalbaki, Ariana Bitton, Amal Kumar

INTRODUCTION & OBJECTIVES

Atopic dermatitis (AD) is associated with skin barrier dysfunction and altered levels and composition of ceramides. Though regular use of moisturisers is cornerstone of therapy for all severities of AD, many moisturisers only hydrate skin without restoring barrier function. The present study evaluates efficacy of a ceramide-containing moisturiser (CCM) formulated using multivesicular emulsion (MVE) technology in improving patient’s quality of life, reducing severity of AD and restoring skin barrier function when used as monotherapy in patients with mild to moderate AD.